Michael Schmelmer

Boehringer Ingelheim International GmbH manufactures pharmaceutical prodcuts. It offers human and animal health products. The company was founded by Albert Boehringer in 1885 and is headquartered in Ingelheim, Germany.

Founded in 2016, Boehringer Ingelheim Corporate Center GmbH is a subsidiary of C.H. Boehringer Sohn AG & Co. KG. The company is based in Ingelheim am Rhein, Germany and specializes in leasing real estate properties.

Boehringer Ingelheim GmbH engages in the provision of central management and other services for the group companies on behalf of C.H. Boehringer Sohn AG & Co. KG. The group specializes in the development, production, and distribution of pharmaceutical products. The company was founded in 1885 and is headquartered in Ingelheim am Rhein, Germany.

Boehringer Ingelheim RCV GmbH & Co. KG develops and supplies biotherapeutic proteins, plasmid DNA and antibody fragments. The company was founded in 1885 by Albert Boehringer and is headquartered in Vienna, Austria.

Part of C.H. Boehringer Sohn AG & Co. KG, Merial Participations GmbH provides veterinary services. The company is based in Ingelheim am Rhein, Germany. The CEOs of the German company are Frank Hübler, Martin Black.

Part of Johnson & Johnson, Janssen Global Services LLC develops treatments for patients in therapeutic areas of healthcare. The company is based in Raritan, NJ.

Part of C.H. Boehringer Sohn AG & Co. KG, Boehringer Ingelheim Verwaltungs GmbH is an investment holding German company. The company is based in Ingelheim am Rhein, Germany. The CEOs are Andreas Neumann, Michael Schmelmer. The company was founded in 2007.

Boehringer Ingelheim Auslandsbeteiligungs GmbH operates an investment holding company, which through its subsidiaries engages in research, development, manufacture, and sale of pharmaceutical products and animal health care services. The company is headquartered in Ingelheim, Ingelheim.

Part of C.H. Boehringer Sohn AG & Co. KG, Boehringer Ingelheim Europe GmbH is a German company that manufactures basic pharmaceutical products. The company is based in Ingelheim am Rhein, Germany. The CEOs are Frank Hübler and Martin Schwarz. The company was founded in 1990.

Part of C.H. Boehringer Sohn AG & Co. KG, Boehringer Ingelheim Animal Health China Participations GmbH provides veterinary services. The company is based in Ingelheim am Rhein, Germany. The CEOs are Frank Hübler, Martin Schwarz. The German company was founded in 2019.

Part of C.H. Boehringer Sohn AG & Co. KG, Boehringer Ingelheim Deutschland GmbH is an investment holding German company. The company is based in Ingelheim am Rhein, Germany. The CEOs of the company are Martin Beck and Sabine Nikolaus.

Part of C.H. Boehringer Sohn AG & Co. KG, Boehringer Ingelheim Animal Health Japan Holding GmbH is a German pharmaceutical company that manufactures pharmaceutical products. The company is based in Ingelheim am Rhein, Germany. The CEOs of the company are Frank Hübler, Martin Schwarz.

Okairos AG develops preventive and therapeutic vaccines against human chronic infectious diseases. Its products include genetic vaccines, adenovirus vector platform, and proprietary cell line. The company was founded by Riccardo Cortese, Alfredo Nicosia, and Antonella Folgori in 2007 and is headquartered in Basel, Switzerland.

Eyevensys SAS develops non-viral gene therapy process for the treatment of ocular illnesses. The firm's process enables prolonged production of all therapeutic proteins through electrotransfer. Its product, the single-used device is designed for treating ocular illnesses. The company was founded by Francine Behar-Cohen on December 8, 2008 and is headquartered in Paris, France.

Boehringer Ingelheim (BIVF) is the venture capital arm of Boehringer Ingelheim International GmbH, itself a subsidiary of C.H. Boehringer Sohn AG & Co. KG. The firm was founded in 2010 and is headquartered in Ingelheim, Germany. It also has two US offices located in Fremont, California, and Cambridge, Massachusetts.

Part of C.H. Boehringer Sohn AG & Co. KG, Boehringer Ingelheim Pharma GmbH & Co., KG is a company that operates research-based pharmaceutical companies and serves. Boehringer Ingelheim Pharma GmbH & Co., KG is based in Ingelheim, Germany. The German company was founded in 1885 by Albert Boehringer. The CEO is Hubertus von Baumbach.

Cobepa SA is an investment holding Belgian company. The company is based in Brussels, Belgium. The company was founded in 1957. The CEO is Jean-Marie Laurent Josi.

Part of Profunda Verwaltungs GmbH & Co. KG, the German company provides asset management services. The company is based in Ingelheim am Rhein, Germany. The CEOs of the company are Hubertus von Baumbach, Christoph Gauger.

Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT.

Boehringer Ingelheim AB develops, produces, markets and sells pharmaceutical products. The firm also provides research, development, manufacturing and marketing services in the therapeutic field of human and veterinary medicine. The company was founded in 1967 is headquartered in Stockholm, Germany.